Robert A. Gabbay, MD, PhD, chief medical officer and senior vice president, Joslin Diabetes Center, says that there are opportunities for treating diabetes within accountable care organizations (ACOs).
Robert A. Gabbay, MD, PhD, chief medical officer and senior vice president, Joslin Diabetes Center, says that there are opportunities for treating diabetes within accountable care organizations (ACOs). Historically, many hospital systems mainly saw revenue from complications associated with diabetes management. ACOs are changing that model of care.
“In order to save money on patients with diabetes, what you’re looking to do is implement better care practices. No longer is it that one—in a sense—profits from the complications of diabetes,” Dr Gabbay says. “Really, now, the savings come from taking better care of diabetes, which is what we’ve always wanted to do all along. But now, finally, the financial incentives are more aligned with what we want to deliver.”
He adds that financial incentives will also encourage providers to innovate as they rethink traditional fee-for-service care models.
A meta-analysis showed that control group outcomes in psilocybin trials for depression were significantly weaker than those in selective serotonin reuptake inhibitor (SSRI) and esketamine trials, suggesting that psilocybin’s large observed treatment effects may be inflated by methodological factors such as functional unblinding and expectancy bias.
Read More
Legal Navigation Services Key to Addressing Disparities in Cancer Care
July 31st 2025A significant number of patients with cancer, caregivers, and health care professionals face significant disparities in legal issues, with the most common needs revolving around health insurance, finances, employment, and disability insurance.
Read More